Steris (STE) EBT Margin Growth (3y) (2021 - 2026)

Steris (STE) EBT Margin Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -305.00
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -9.00
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -222.00
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 923.00
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -480.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2,114.00
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 1,391.00
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -176.00
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 329.00
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -122.00

Historic Data

Download Data
DateValue
Mar 31, 2026 329.00
Dec 31, 2025 181.00
Sep 30, 2025 273.00
Jun 30, 2025 279.00
Mar 31, 2025 310.00
Dec 31, 2024 160.00
Sep 30, 2024 718.00
Jun 30, 2024 1,669.00
Mar 31, 2024 -211.00
Dec 31, 2023 -263.00
Sep 30, 2023 -511.00
Jun 30, 2023 -214.00
Mar 31, 2023 -212.00
Dec 31, 2022 -188.00
Sep 30, 2022 -132.00
Jun 30, 2022 -38.00
Mar 31, 2022 -708.00
Dec 31, 2021 679.00
Sep 30, 2021 -654.00
Jun 30, 2021 -1,599.00